Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Epstein-Barr Virus Infections × valomaciclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Infectious Mononucleosis 1 Epstein-Barr Virus Infections 1

Interventions

pembrolizumab 2 Rituximab 2 valomaciclovir 1 threonic acid 1 otelixizumab 1 brincidofovir 1 Valganciclovir 1 Valacyclovir 1 Tenofovir 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Matrix-M 1 Magnesium Sulfate 1 Lenalidomide 1 Brentuximab Vedotin 1 Bevacizumab 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00575185 2017-03-22

Mono6

University of Minnesota

Phase 1/2 Completed

23 enrolled 8 charts

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡